Published in Blood Weekly, March 9th, 2006
A new study in The Lancet (February 4, 2006, Vol. 367, pages 404-411) shows that self-monitoring of one's oral anticoagulation therapy can keep patients in therapeutic range more frequently, reducing the risk of death by one-third from all causes.
Another previous study in the Annals of Internal Medicine shows that the ease and convenience of testing INR at home increases patient compliance and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.